Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Bioxyne Limited ( (AU:BXN) ).
Bioxyne Limited announced that all resolutions were successfully passed during its Annual General Meeting held on November 26, 2025. The resolutions included the re-election of directors, approval of performance rights, and ratification of placement shares and options, indicating strong shareholder support and potential for strategic growth initiatives.
More about Bioxyne Limited
Bioxyne Limited operates in the biotechnology industry, focusing on the development and commercialization of health and wellness products. The company primarily offers probiotic and immune health products, targeting both consumer and healthcare markets.
Average Trading Volume: 3,664,650
Technical Sentiment Signal: Buy
Current Market Cap: A$81.02M
For an in-depth examination of BXN stock, go to TipRanks’ Overview page.